Article PDF
References
Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance. A report from the drug resistant Steptococcus pneumoniae therapeutic working group. Arch Intern Med. 2000;160:1399–1408.
Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31:347–82.
Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730–54.
Levin KP, Hanusa BH, Rotondi A, et al. Arterial blood gas and pulse oximetry in initial management of patients with community-acquired pneumonia. J Gen Intern Med. 2001;16:590–8.
Halm EA, Switzer GE, Mittman BS, Walsh MB, Chang CH, Fine MJ. What factors influence physicians’ decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? J Gen Intern Med. 2001;16:599–605.
Austrian R, Mirick GS, Rogers DE, et al. The efficacy of modified oral penicillin therapy of pneumococcal lobar pneumonia. Bull Johns Hopkins Hosp. 1951;88:264–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bartlett, J.G. Managing community-acquired pneumonia. J GEN INTERN MED 16, 642–643 (2001). https://doi.org/10.1046/j.1525-1497.2001.016009640.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.2001.016009640.x